SEC Form 4 · accession 0001553878-15-000025
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry E Greene
Officer — President and COO
Period of report
May 26, 2015
Accepted (ET)
May 28, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2015 | M | 67,379 | $13.12 | A | 90,771 | D | |
| Common Stock | May 26, 2015 | S | 67,379 | $125.00 | D | 23,392 | D | |
| Common StockF2 | holding | — | — | — | 2,591 | I | By Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F1 | $13.12 | May 26, 2015 | M | 67,379 | D | — | Dec 7, 2015 | Common Stock | 67,379 | 6,621 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2015. The options exercised and sold by the reporting person were due to expire on December 7, 2015.
- F2The reporting person owns 2,591 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F3The stock option vested as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.